UAP1 and prostate cancer: Similarly, Itkonen and coworkers showed that siRNA targeting AGX1/UAP1 gene in PC3 cells led to increased sensitivity to tunicamycin treatment in cultured prostate cancer cells, as well as over 60% decrease in UGP-GlcNAc and UDP-GalNAc [19].